The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque Assay
Abstract
The human T-cell lines MT-2 and MT-4 carry the human T-cell leukemia virus type I (HTLV-I). When MT-2 and MT-4 were infected with HTLV-III, the probable etiologic agent of the acquired immune deficiency syndrome (AIDS), rapid cytopathogenic effects and cytotoxicity were observed that made it possible to titrate the biologically active virus in a plaque-forming assay. The cytopathogenic effects were preceded by the rapid induction and increase of HTLV-III antigens as revealed by immunofluorescence and immunoprecipitation. Activities of HTLV-III were neutralized by the human antibodies against the virus when immunofluorescence and plaque assays were used. Essentially the same results were obtained with the lymphadenopathy-associated virus (LAV 1 ).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12
REED, L. J., & MUENCH, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 19,926
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043
PLAQUE FORMATION AND ISOLATION OF PURE LINES WITH POLIOMYELITIS VIRUSES
Dulbecco, R., & Vogt, M. (1954) · Journal of Experimental Medicine · doi:10.1084/jem.99.2.167 · Cited by 3,824
Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,641
Popovic, M., Sarngadharan, M. G., Read, E., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6200935 · Cited by 3,535
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.-C., & Montagnier, L. (1984) · Nature · doi:10.1038/312767a0 · Cited by 2,436
Complete nucleotide sequence of the AIDS virus, HTLV-III
Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., Doran, E. R., Rafalski, J. A., Whitehorn, E. A., Baumeister, K., et al. (1985) · Nature · doi:10.1038/313277a0 · Cited by 2,245
Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS
Levy, J. A., Hoffman, A. D., Kramer, S. M., Landis, J. A., Shimabukuro, J. M., & Oshiro, L. S. (1984) · Science · doi:10.1126/science.6206563 · Cited by 1,436
Cited by
Interaction of silver nanoparticles with HIV-1
Elechiguerra, J. L., Burt, J. L., Morones, J. R., Camacho-Bragado, A., Gao, X., Lara, H. H., & Yacaman, M. J. (2005) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-3-6 · Cited by 1,709
Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter, J., & De Clercq, E. (1988) · Journal of Virological Methods · doi:10.1016/0166-0934(88)90134-6 · Cited by 1,642
HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
Larder, B. A., Darby, G., & Richman, D. D. (1989) · Science · doi:10.1126/science.2467383 · Cited by 1,559
Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
Larder, B. A., & Kemp, S. D. (1989) · Science · doi:10.1126/science.2479983 · Cited by 1,163
Kimpton, J., & Emerman, M. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2232-2239.1992 · Cited by 908
Pathogenesis of human immunodeficiency virus infection
Levy, J. A. (1993) · Microbiological Reviews · doi:10.1128/mr.57.1.183-289.1993 · Cited by 839
Dual Infection of the Central Nervous System by AIDS Viruses with Distinct Cellular Tropisms
Koyanagi, Y., Miles, S., Mitsuyasu, R. T., Merrill, J. E., Vinters, H. V., & Chen, I. S. Y. (1987) · Science · doi:10.1126/science.3646751 · Cited by 817
Self-citationHIV-1 replication is controlled at the level of T cell activation and proviral integration.
Stevenson, M., Stanwick, T. L., Dempsey, M. P., & Lamonica, C. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08274.x · Cited by 800
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M. J., Breslin, H. J., Raeymaeckers, A., Gelder, J. V., Woestenborghs, R., Heykants, J., et al. (1990) · Nature · doi:10.1038/343470a0 · Cited by 756
The HIV lipidome: A raft with an unusual composition
Brügger, B., Glass, B., Haberkant, P., Leibrecht, I., Wieland, F. T., & Kräusslich, H.-G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511136103 · Cited by 708
A trimeric structural domain of the HIV-1 transmembrane glycoprotein
Lu, M., Blacklow, S. C., & Kim, P. S. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb1295-1075 · Cited by 701
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
Scarlatti, G., Tresoldi, E., Björndal, Å., Fredriksson, R., Colognesi, C., Kui Deng, H., Malnati, M. S., Plebani, A., Siccardi, A. G., Littman, D. R., et al. (1997) · Nature Medicine · doi:10.1038/nm1197-1259 · Cited by 633
Potential Mechanism for Sustained Antiretroviral Efficacy of AZT-3TC Combination Therapy
Larder, B. A., Kemp, S. D., & Harrigan, P. R. (1995) · Science · doi:10.1126/science.7542804 · Cited by 623
The trans-activator gene of the human T cell lymphotropic virus type III is required for replication
Dayton, A. (1986) · Cell · doi:10.1016/0092-8674(86)90017-6 · Cited by 621
Tisdale, M., Kemp, S. D., Parry, N. R., & Larder, B. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5653 · Cited by 603
Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60
Hallenberger, S., Bosch, V., Angliker, H., Shaw, E., Klenk, H.-D., & Garten, W. (1992) · Nature · doi:10.1038/360358a0 · Cited by 582
Baba, M., Snoeck, R., Pauwels, R., & de Clercq, E. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.11.1742 · Cited by 544
L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.
Vacca, J. P., Dorsey, B. D., Schleif, W. A., Levin, R. B., McDaniel, S. L., Darke, P. L., Zugay, J., Quintero, J. C., Blahy, O. M., & Roth, E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4096 · Cited by 527
Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins
Gelderblom, H. R., Hausmann, E. H. S., Özel, M., Pauli, G., & Koch, M. A. (1987) · Virology · doi:10.1016/0042-6822(87)90449-1 · Cited by 521
Pathogenesis of Infection with Human Immunodeficiency Virus
Epstein, F. H., Ho, D. D., Pomerantz, R. J., & Kaplan, J. C. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707303170505 · Cited by 495
Baba, M., Pauwels, R., Balzarini, J., Arnout, J., Desmyter, J., & De Clercq, E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.6132 · Cited by 465
Connor, R. I., Mohri, H., Cao, Y., & Ho, D. D. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.1772-1777.1993 · Cited by 455
Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1.
Terai, C., Kornbluth, R. S., Pauza, C. D., Richman, D. D., & Carson, D. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115188 · Cited by 421
Clapham, P. R., Weber, J. N., Whitby, D., McIntosh, K., Dalgleish, A. G., Maddon, P. J., Deen, K. C., Sweet, R. W., & Weiss, R. A. (1989) · Nature · doi:10.1038/337368a0 · Cited by 402
Replicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1
Martinez-Picado, J., Savara, A. V., Sutton, L., & D’Aquila, R. T. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3744-3752.1999 · Cited by 396
Soluble CD4 molecules neutralize human immunodeficiency virus type 1
Traunecker, A., Lüke, W., & Karjalainen, K. (1988) · Nature · doi:10.1038/331084a0 · Cited by 393
In Vitro Antiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor
Kobayashi, M., Yoshinaga, T., Seki, T., Wakasa-Morimoto, C., Brown, K. W., Ferris, R., Foster, S. A., Hazen, R. J., Miki, S., Suyama-Kagitani, A., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01209-10 · Cited by 382
Baba, M., Pauwels, R., Herdewijn, P., De Clercq, E., Desmyter, J., & Vandeputte, M. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90460-8 · Cited by 342
Balzarini, J., Herdewijn, P., & De Clercq, E. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83322-1 · Cited by 338
Wiegers, K., Rutter, G., Kottler, H., Tessmer, U., Hohenberg, H., & Kräusslich, H.-G. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2846-2854.1998 · Cited by 336
Zhang, Y. M., Imamichi, H., Imamichi, T., Lane, H. C., Falloon, J., Vasudevachari, M. B., & Salzman, N. P. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6662-6670.1997 · Cited by 320
Boucher, C. A., Cammack, N., Schipper, P., Schuurman, R., Rouse, P., Wainberg, M. A., & Cameron, J. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2231 · Cited by 313
Charneau, P., Alizon, M., & Clavel, F. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.2814-2820.1992 · Cited by 312
Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity
Chesebro, B., & Wehrly, K. (1988) · Journal of Virology · doi:10.1128/jvi.62.10.3779-3788.1988 · Cited by 304
Baba, M., Tanaka, H., De Clercq, E., Pauwels, R., Balzarini, J., Schols, D., Nakashima, H., Perno, C.-F., Walker, R. T., & Miyasaka, T. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92756-3 · Cited by 288
Maturation-Dependent HIV-1 Surface Protein Redistribution Revealed by Fluorescence Nanoscopy
Chojnacki, J., Staudt, T., Glass, B., Bingen, P., Engelhardt, J., Anders, M., Schneider, J., Müller, B., Hell, S. W., & Kräusslich, H.-G. (2012) · Science · doi:10.1126/science.1226359 · Cited by 283
NARA, P. L., HATCH, W. C., DUNLOP, N. M., ROBEY, W. G., ARTHUR, L. O., GONDA, M. A., & FISCHINGER, P. J. (1987) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1987.3.283 · Cited by 272
Tunón, H., Olavsdotter, C., & Bohlin, L. (1995) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(95)01285-l · Cited by 266
Fäcke, M., Janetzko, A., Shoeman, R. L., & Kräusslich, H. G. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4972-4980.1993 · Cited by 198
Potential Role of the Formation of Tunneling Nanotubes in HIV-1 Spread in Macrophages
Hashimoto, M., Bhuyan, F., Hiyoshi, M., Noyori, O., Nasser, H., Miyazaki, M., Saito, T., Kondoh, Y., Osada, H., Kimura, S., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1500845 · Cited by 138
“To further test this hypothesis, we next screened M-Sec cell lines and found that an HTLV-1–infected T cell line MT-2 (37) expressed M-Sec at similar levels to MDMs (Fig.”
ResultInfluentialMücksch, F., Citir, M., Lüchtenborg, C., Glass, B., Traynor-Kaplan, A., Schultz, C., Brügger, B., & Kräusslich, H.-G. (2019) · Scientific Reports · doi:10.1038/s41598-019-53939-z · Cited by 73
Metadata
- Authors
- Harada, S., Koyanagi, Y., & Yamamoto, N.
- Venue
- Science
- Published
- 1985-08-09
- Volume
- 229
- Issue
- 4713
- Pages
- 563-566
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2015326137
- Cited by
- 857
- References
- 28
- FWCI
- 9.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.